Dublin, March 29, 2016 -- Research and Markets has announced the addition of the "Global Mice Model (Model, Products, and Services) Market Outlook: 2015-2021" report to their offering.
The global mice model (model, products, and services) market is expected to grow at a CAGR of 9.6% from 2015 to 2021 to reach $2,657.8 million by 2021
This market is mainly driven by the increasing investment in biomedical research, advancements in biotechnology and biopharmaceutical industries, genetic similarity of mice to humans, and increasing demand for personalized humanized mice models in personalized medicine. However, strict regulations and laws for ethical use of animals in research, advances in zebrafish model development, increased use of rat models, and alternative methods for animal testing could restrict the growth of mice model and services market to certain extent.
The global mice model and services market is mainly dominated by three main players, namely, Charles River Laboratories, The Jackson laboratories, and Taconic Farms International, Inc. in 2015. Other prominent players in the global market include Harlan Laboratories, Inc., genOway S.A., Covance Inc., Crescendo Biologics Limited, Deltagen, Inc., TransGenic , Inc., SAGE Labs, ImmunoGenes AG, Mirimus, Inc., and Ablexis LLC.
The research report on the global mice model market offers a comprehensive analysis of mice model market with respect to model type, technology, diseases, products, and services. The report also emphasizes on the various segments of mice care products which are important aspects of the global mice care market across the globe. Comprehensive geographical analysis of the mice model market is provided by segmenting total market on the basis of major continents which is further sub-segmented to get the country level market scenario.
Key Topics Covered:
1 Introduction to Global Mice Model Market
2 Executive Summary
3 Market Insights
3.1 Key Drivers
3.2 Key Restraints
3.3 Issues and Opportunities
3.4 Key Challenges
3.5 Market Share Analysis
4 Global Mice Model- Market Crackdown ($ Value Analysis), By Technology
5 Global Mice Model- Market Crackdown ($ Value Analysis), By Type
6 Global Mice Model- Market Crackdown ($ Value Analysis), By Diseases
7 Global Mice Model- Market Crackdown ($ Value Analysis), By Services
8 Global Mice Model- Market Crackdown ($ Value Analysis), By Mice Care Products
9 Mice Model- Market Crackdown ($ Value Analysis), By Geography
10 Competitive Landscape
10.1 Agreements Collaborations, and Partnerships
10.2 New Product Launches
10.3 Grants and Funds
10.4 Expansions
10.5 Mergers and Acquisitions
10.6 Patents
10.7 Other Developments
11 Company Profiles
11.1 Ablexis LLC
11.2 AVEO Pharmaceuticals, Inc.
11.3 BIOCYTOGEN
11.4 Charles River Laboratories, Inc.
11.5 Laboratory Corporation of America Holdings
11.6 Crescendo Biologics
11.7 Deltagen, Inc.
11.8 genOway, SA
11.9 Harbour Antibodies BV
11.10 Envigo
11.11 ImmunoGenes AG
11.12 inGenious Targeting Laboratory (iTL)
11.13 Mutant Mouse Regional Resource Centers
11.14 Taconic Biosciences, Inc.
11.15 The Jackson Laboratory
11.16 TransGenic, Inc.
For more information visit http://www.researchandmarkets.com/research/3gqgmn/global_mice_model
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Laboratory Testing


Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 



